Novartis sells portions of Sandoz US portfolio to Aurobindo
06-09-2018
Sanofi to launch €66m R&D hub in China
05-07-2018
filograph / iStockphoto.com
Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Novartis, Nerve Live, big data, drug development, gene sequencing, clinical trials
